Jonas Hansson
Chief Executive Officer
pharmaceutical sciences
Wilson Therapeutics
Netherlands
Biography
Education: M.Sc. in pharmacy, Uppsala University and MBA, Stockholm School of Economics. Other current assignments: Venture Partner of HealthCap VI GP SA and HealthCap VII GP SA. Previous assignments (last five years): Board member of ReVENT Medical, Inc. Holdings in the Company: 50,000 ordinary shares, 390,000 stock options and 30,000 performance shares LTIP 2017.
Research Interest
